Cite
Therapeutic patterns and migraine disease burden in switchers of CGRP-targeted monoclonal antibodies – insights from the German NeuroTransData registry.
MLA
Hong, Ja Bin, et al. “Therapeutic Patterns and Migraine Disease Burden in Switchers of CGRP-Targeted Monoclonal Antibodies – Insights from the German NeuroTransData Registry.” Journal of Headache & Pain, vol. 25, no. 1, June 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s10194-024-01790-7.
APA
Hong, J. B., Israel-Willner, H., Peikert, A., Schanbacher, P., Tozzi, V., Köchling, M., Reuter, U., & Raffaelli, B. (2024). Therapeutic patterns and migraine disease burden in switchers of CGRP-targeted monoclonal antibodies – insights from the German NeuroTransData registry. Journal of Headache & Pain, 25(1), 1–10. https://doi.org/10.1186/s10194-024-01790-7
Chicago
Hong, Ja Bin, Heike Israel-Willner, Andreas Peikert, Peter Schanbacher, Viola Tozzi, Monika Köchling, Uwe Reuter, and Bianca Raffaelli. 2024. “Therapeutic Patterns and Migraine Disease Burden in Switchers of CGRP-Targeted Monoclonal Antibodies – Insights from the German NeuroTransData Registry.” Journal of Headache & Pain 25 (1): 1–10. doi:10.1186/s10194-024-01790-7.